Tivozanib (AV-951) In Vitro Workflow Guide
2026-09-05
Build sharper anti-angiogenic experiments with Tivozanib (AV-951), from VEGFR pathway validation to time-resolved viability and cell-death profiling. This workflow emphasizes solvent control, exposure kinetics, orthogonal readouts, and combination testing so apparent growth inhibition is not mistaken for cytotoxicity.
CSBTA Pharmacokinetics in MASH Mice
2026-09-05
This study integrates plasma pharmacokinetics, tissue distribution, cellular accumulation, and enzyme–transporter analysis to explain how MASH alters exposure to Corydalis saxicola Bunting total alkaloids. Its findings show that disease status and repeated dosing can increase systemic and hepatic exposure, providing a mechanistic basis for more cautious dose-regimen design in MASLD/MASH research.
Actinomycin D in TNBC Transcriptional Stress
2026-09-04
Actinomycin D is a powerful transcriptional shutoff tool for connecting mRNA stability with PD-L1 biology in triple-negative breast cancer. This guide translates RBMS1 pathway findings into assay design, controls, and interpretation strategies for cancer research.
Intracellular Protein Stability Under Osmotic Stress
2026-09-04
Hollembeak and Model introduced a long-duration, single-cell strategy for measuring intracellular protein concentration during osmotic stress, combining quantitative phase imaging with cell-volume measurement by exclusion of an absorbing dye. Their findings show that cytoplasmic protein concentration is unusually stable across broad osmotic conditions, while severe hypotonic stress triggers dehydration and protein-free vacuole formation rather than simple dilution.
TNF-alpha recombinant murine protein for apoptosis
2026-09-03
Use TNF-alpha recombinant murine protein as a controlled inflammatory and apoptotic stimulus, then pair it with RNA Pol II perturbation to separate receptor-driven signaling from transcription-independent cell death. This workflow combines dose-resolved cell culture cytokine treatment, mechanistic controls, and practical troubleshooting for murine models.
UK-5099 for Mitochondrial Immunometabolism
2026-09-03
UK-5099 (PF-1005023) gives researchers a practical way to test how mitochondrial pyruvate entry shapes cytokine output, respiration, and cellular energy balance. This workflow-focused guide combines standardized whole-blood stimulation with formulation controls, metabolic readouts, and cross-model validation strategies.
Ouabain: From Ion Pump Inhibition to Translation
2026-09-02
A thought-leadership guide to using Ouabain as a selective Na+/K+-ATPase inhibitor, connecting extracellular pump engagement with Na+/Ca²⁺ exchange, calcium signaling, vascular physiology, and translational study design.
Halazone and Sodium Current Inactivation in Frog Nerves
2026-09-02
Rack, Rubly, and Waschow compared Halazone with selective chemical reagents in voltage-clamped frog nerve fibers to test whether methionine, tyrosine, arginine, or membrane lipids govern sodium-current inactivation. Their results challenged a methionine-centered mechanism and showed that Halazone and hypochlorous acid strongly disrupt inactivation, providing a useful mechanistic framework for interpreting this antimicrobial sulfonamide derivative in neurophysiological experiments.
DNA Frameworks for Efficient Enzymatic Synthesis
2026-09-01
The reference study introduces tetrahedral DNA nanostructures as an ordered interface for improving enzyme access to primers during enzymatic oligonucleotide synthesis. Its framework increases substrate affinity and reaction kinetics, reduces deletion errors, and supports a 60-nucleotide DNA information-storage demonstration with a reported 96.82% stepwise yield.
EdU Imaging Kits (Cy5) for S-Phase Analysis
2026-09-01
EdU Imaging Kits (Cy5) provide click-chemistry detection of newly synthesized DNA for fluorescence microscopy and flow cytometry. The 5-ethynyl-2'-deoxyuridine imaging kit supports morphology-preserving S-phase measurements that can complement mechanistic studies of endothelial proliferation.
AP-2α, MGMT, and TMZ Resistance in Recurrent GBM
2026-08-31
The reference study identifies AP-2α as a transcriptional suppressor of MGMT and links its loss to temozolomide resistance in recurrent glioblastoma. By combining promoter-binding assays, DNA-damage measurements, retinoic acid treatment, and an intracranial relapse model, the work suggests that restoring AP-2α may improve TMZ response while offering a framework for mechanistic DNA repair inhibition studies.
ML385: Practical NRF2 Inhibition Workflows
2026-08-30
ML385 enables controlled NRF2 signaling pathway inhibition in cancer, oxidative stress, ferroptosis, and therapeutic-resistance studies. This guide translates evidence from non-small cell lung cancer and alcoholic liver disease models into practical assay design, dosing logic, controls, and troubleshooting steps.
Nuclear-Targeted Nanorods Activate STING
2026-08-29
The reference study develops PFPD, a nuclear-targeted peptide nanorod that co-delivers the photosensitizer PpIX and the STING agonist DMXAA. Light-triggered nuclear DNA damage supplies an endogenous immunostimulatory signal that cooperates with DMXAA to activate innate and adaptive antitumor immunity against lung metastatic tumors.
Fluorouracil Workflows for Solid Tumor Research
2026-08-29
Build reproducible Fluorouracil and 5-Fluorouracil assays around concentration–response, DNA-replication inhibition, apoptosis, and drug-resistance endpoints. This workflow connects HT-29 benchmarking with the SMYD2–miR-125b–P-glycoprotein findings reported in renal cell carcinoma research.
Neomycin Sulfate for Structure-First Assays
2026-08-28
Neomycin sulfate is an aminoglycoside antibiotic that functions as a mechanistic probe for RNA, DNA, and ion-channel biology. This article connects its structure-selective activities with assay-design lessons from an allergic-rhinitis microbiome study without overstating translational relevance.
458 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page